MyFinsight
Home
Blog
About
Contact
Back
Cash Flow
Aldeyra Therapeutics, Inc. (ALDX)
Aldeyra Therapeutics, Inc. (ALDX)
source: myfinsight.com
Download
Download image
Proceeds from exercise of
stock options
$71,140
Net cash provided by
financing activities
$71,140
Net decrease in cash
and cash...
-$5,038,949
Canceled cashflow
$71,140
Prepaid expenses and
other current assets
-$470,688
Depreciation and
amortization expense
$66,599
Non-cash interest
expense
$50,368
Net cash used in
operating activities
-$5,110,089
Canceled cashflow
$587,655
Net loss
-$3,452,619
Accrued expenses and
other liabilities
-$1,240,466
Stock-based compensation
-$987,554
Accounts payable
-$17,105
Back